Show simple item record

dc.contributor.authorMullins, L. J.
dc.contributor.authorPeter, A.
dc.contributor.authorWrobel, N.
dc.contributor.authorAl-Dujaili, Emad A. S.
dc.contributor.authorMcNeilly, J. R.
dc.contributor.authorBrownstein, D. G.
dc.contributor.authorMcNeilly, J. R.
dc.contributor.authorMullins, J. J.
dc.contributor.authorKenyon, C. J.
dc.date.accessioned2018-06-29T21:32:57Z
dc.date.available2018-06-29T21:32:57Z
dc.date.issued2008
dc.identifierER796
dc.identifier.citationMullins, L., Peter, A., Wrobel, N., Al-Dujaili, E., McNeilly, J., Brownstein, D., McNeilly, J., Mullins, J. & Kenyon, C. (2008) Targeting Cyp11b1 expression in mice to model sequelae of congenital adrenal hyperplasia, , , , pp. OC29,
dc.identifier.urihttp://www.endocrine-abstracts.org/ea/0015/ea0015oc29.htm
dc.identifier.urihttps://eresearch.qmu.ac.uk/handle/20.500.12289/796
dc.description.abstractWe have created transgenic mice in which Cyp11b1, the gene encoding 11_-hydroxylase, has been knocked out. Since mice do not secrete adrenal androgens, this knockout line allows a more detailed investigation of phenotypes associated with congenital adrenal hyperplasia (CAH) without the overwhelming virilisation that characterises patients with CAH. Starting with a BAC containing the mouse Cyp11b1/b2 locus and including flanking up- and downstream sequences, a construct was engineered in which exons 3-7 of Cyp11b1 were substituted with DNA encoding the fluorescent reporter protein ECFP. An IRES site preceding and a farnesylation signal following the ECFP gene were added to the construct which was then homologously recombined in ES cells before injection into blastocysts. Successful targeting of the Cyp11b1 gene was confirmed in ES cells by FISH analysis and in homozygous transgenic mice by the absence of adrenal Cyp11b1 mRNA (RT-PCR) and 11beta-hydroxylase (immunocytochemistry) expression. The expected increase in adrenal mass (3-fold, P<0.001) was observed with changes due to cell hypertrophy rather than hyperplasia. Urinary steroid profiles showed marked reductions in corticosterone (9.5-fold, P<0.001) and concomitant increases of earlier intermediates in the glucocorticoid biosynthetic pathway (deoxycorticosterone 25-fold, P<0.001; progesterone 3-fold, P<0.001). Urinary DHEA and testosterone were higher in both males and females although not to the extent seen in patients with CAH. Estradiol in females was unaffected. Several unexpected phenotypes relating to reproduction were observed. In initial crosses of heterozgotes, offspring carrying the Cyp11b1 null allele were underrepresented. Also female homozygote mice were infertile with poorly defined corpora lutea, endometrial hyperplasia, and late-onset adenomyosis. We conclude that Cyp11b1 null mice exhibit signs of glucocorticoid deficiency, mineralocorticoid and progesterone excess and mild hyperandrogenism. Infertility which is known to be a problem of CAH patients, appears to be caused by abnormalities in uterine and ovarian tissues.
dc.format.extentOC29
dc.titleTargeting Cyp11b1 expression in mice to model sequelae of congenital adrenal hyperplasia
dc.typeconference_item
dcterms.accessRightsnone
dc.description.facultysch_die
dc.description.ispublishedpub
dc.description.eprintid796
rioxxterms.typeconference_item
qmu.authorAl-Dujaili, Emad A. S.
dc.description.statuspub


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record